Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...

As the markets for weight-loss drugs develop, pharma companies are having to adapt in search of the next big thing.

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

The once-monthly drug is still under study but could provide added convenience and another option for patients.

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...

The so-called 'King Kong' of weight-loss drugs can cause side effects like nausea, but may also help users build healthy ...

Cardiologists need to embrace the wave of new drugs, say experts, particularly since they can reduce the risk of CVD.

Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while ...

SPRINGFIELD, Mo. (KY3) - Should you try a GLP-1 weight loss drug or surgery? Dr. Tim Woods of CoxHealth shares advice for ...

Drugmakers are racing to develop the next wave of obesity and diabetes medications that they hope will be even more powerful ...